IPP Bureau
JB Pharma records revenue growth of 22% to Rs. 762 Cr
By IPP Bureau - May 25, 2023
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
GenWorks launches FenomPro breath analyser
By IPP Bureau - May 25, 2023
Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients
Oncodesign Services and Veritas In Silico jointly to develop mRNA-targeted small molecule drugs
By IPP Bureau - May 25, 2023
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Tata 1mg-backed 5C Network launches diagnostics-on-demand platform Prodigi PASS
By IPP Bureau - May 24, 2023
5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience
Lonza launches TheraPEAK T-VIVO cell culture medium to accelerate cell therapy development
By IPP Bureau - May 24, 2023
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
Neutec introduces the oCelloscope automated microbial live-cell imaging technology
By IPP Bureau - May 24, 2023
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
Venus Remedies gets Kenyan GMP certification for its manufacturing facilities in Baddi
By IPP Bureau - May 24, 2023
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
By IPP Bureau - May 24, 2023
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
Shilpa Medicare Analytical Services Division gets VAI status from USFDA after GMP inspection
By IPP Bureau - May 23, 2023
This is the second US FDA GMP inspection of this facility within one year
Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr
By IPP Bureau - May 23, 2023
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
Agilent to appeal patent office decision on CRISPR gRNA patents
By IPP Bureau - May 23, 2023
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Freenome acquires global immunodiagnostics developer Oncimmune
By IPP Bureau - May 23, 2023
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Roche introduces navify sample tracking for labs to track patient test samples
By IPP Bureau - May 23, 2023
navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
Anuh Pharma posts Q4 FY23 PAT at Rs. 9.62 Cr
By IPP Bureau - May 22, 2023
Anuh Pharma has reported total income of Rs. 158.34 crores during the period ended March 31, 2023
Zydus receives final approval from the USFDA for Ephedrine Sulfate Injection
By IPP Bureau - May 22, 2023
Ephedrine Sulfate Injection USP, 50 mg/mL had annual sales of USD 52 mn in the United States
